Position in PFE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$162,057,604
-$10,658,683 QoQ
Shares Held
6,729,967
+9.4% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#73
of 2,820 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swedbank AB holds $5,796,975,204 across 10 Drug Manufacturers - General names. PFE ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,781,310 | $2,136,556,831 | |
| 2 | JNJ |
Johnson & Johnson
|
3,624,513 | $920,517,565 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,360,649 | $817,343,396 | |
| 4 | ABBV |
AbbVie Inc.
|
2,634,628 | $662,977,789 | |
| 5 | AZN |
Astrazeneca PLC
|
2,241,677 | $425,066,792 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,903,177 | $240,447,381 | |
| 7 | AMGN |
Amgen Inc
|
517,466 | $187,384,787 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,043,205 | $175,349,471 |
All Filings in PFE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $162,057,604 | 6,729,967 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $172,716,287 | 6,150,865 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $136,707,771 | 5,490,272 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $123,906,386 | 4,862,888 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $111,184,734 | 4,586,829 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $136,130,045 | 5,131,174 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $166,284,349 | 5,745,831 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $159,715,295 | 5,708,195 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $172,901,675 | 6,230,691 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $176,413,920 | 6,127,611 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $197,734,496 | 5,961,245 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $204,405,535 | 5,572,670 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $238,653,928 | 5,849,361 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $316,464,797 | 6,176,128 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $293,915,352 | 6,716,530 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $367,308,745 | 7,005,698 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $351,227,196 | 6,784,377 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $308,806,698 | 5,229,580 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $225,057,909 | 5,232,688 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $205,069,836 | 5,236,717 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $167,651,969 | 4,627,435 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||